AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsueh, P.-R.
Right arrow Articles by Lin, F.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsueh, P.-R.
Right arrow Articles by Lin, F.-Y.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 2004, p. 1361-1364, Vol. 48, No. 4
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.4.1361-1364.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Increasing Prevalence of Methicillin-Resistant Staphylococcus aureus Causing Nosocomial Infections at a University Hospital in Taiwan from 1986 to 2001

Po-Ren Hsueh,1,2,3* Lee-Jene Teng,4 Wen-Hwei Chen,3 Huei-Ju Pan,1,3 Mei-Lin Chen,1,3 Shan-Chwen Chang,2,3 Kwen-Tay Luh,1,2 and Fang-Yue Lin3

Departments of Laboratory Medicine,1 Internal Medicine,2 Committee of Infection Control, National Taiwan University Hospital,3 School of Medical Technology, National Taiwan University College of Medicine, Taipei, Taiwan4

Received 3 June 2003/ Returned for modification 1 September 2003/ Accepted 30 December 2003

A rapid emergence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection (from 26.3% in 1986 to 77% in 2001) was found. The susceptibility of 200 nonduplicate blood isolates of MRSA and 100 MRSA isolates causing refractory bacteremia to 22 antimicrobial agents disclosed that glycopeptides, quinupristin-dalfopristin, and linezolid remained the most active agents.

* Corresponding author. Mailing address: Department of Laboratory Medicine, National Taiwan University Hospital, No 7, Chung-Shan South Rd., Taipei, Taiwan. Phone: 886-2-23123456, ext. 5363. Fax: 886-2-23224263. E-mail: hsporen{at}ha.mc.ntu.edu.tw.

Antimicrobial Agents and Chemotherapy, April 2004, p. 1361-1364, Vol. 48, No. 4
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.4.1361-1364.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2004 by the American Society for Microbiology. All rights reserved.